首页> 外文期刊>Cancer biology & therapy >Osteosarcoma: limb salvaging treatment by ultrasonographically guided high-intensity focused ultrasound.
【24h】

Osteosarcoma: limb salvaging treatment by ultrasonographically guided high-intensity focused ultrasound.

机译:骨肉瘤:通过超声引导下的高强度聚焦超声进行肢体抢救治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this study was to prospectively evaluate the use of ultrasonographically guided high-intensity focused ultrasound (HIFU) in the salvage of limbs in patients with osteosarcoma. Seven patients underwent HIFU ablation. Laboratory and radiologic examinations were performed after intervention. Changes in symptoms and survival time were noted at follow-up. No severe complications were observed, and preexisting severe pain disappeared in patients treated with HIFU. Alkaline phosphatase did not show statistically significant changes before and after HIFU treatment, although Alkaline phosphatase did change 1 mo and 2 mo after HIFU. Complete response of the tumor was achieved in three patients with osteosarcoma. Partial response was achieved in another three patients treated with HIFU. Pulmonary metastasis was noted in only one patient 5 mo after HIFU. The median survival time was 68 mo. All patients were alive 3 y after HIFU treatment. Five patients were alive at follow-up visits after 5 y. One patient died from cachexia and infection after 4 y, another patient died of cardiac arrest attack after 4 y. Three patients died of lung dysfunction from pulmonary metastases after 5 y. The five-year survival rate was 71.4%. The authors concluded that HIFU ablation was a safe and feasible method of treatment of osteosarcoma which salvages the limb, but large-scale randomized clinical trials are necessary for confirmation.
机译:这项研究的目的是前瞻性评估超声引导下高强度聚焦超声(HIFU)在骨肉瘤患者四肢的抢救中的应用。 7例患者接受了HIFU消融术。干预后进行实验室检查和放射学检查。随访时观察到症状和生存时间的变化。没有观察到严重的并发症,并且HIFU治疗的患者中先前存在的严重疼痛消失了。 HIFU治疗前后,碱性磷酸酶均无统计学意义的变化,尽管HIFU治疗后1mo和2mo时碱性磷酸酶均发生了变化。三名骨肉瘤患者实现了肿瘤的完全缓解。在另外三例接受HIFU治疗的患者中获得了部分缓解。 HIFU后仅5个月发现一名患者发生肺转移。中位生存时间为68 mo。 HIFU治疗后3年所有患者均存活。 5年后,有5例患者在随访中还活着。一名患者在4年后死于恶病质和感染,另一名患者在4年后死于心脏骤停发作。 3例患者在5年后因肺转移而死于肺功能不全。五年生存率为71.4%。作者得出结论,HIFU消融术是挽救肢体的骨肉瘤的一种安全可行的方法,但需要进行大规模的随机临床试验来证实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号